Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lupus erythematosus, systemic
Phenotype C0007222|cardiovascular disease
Sentences 14
PubMedID- 25379191 Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus.
PubMedID- 23052654 Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus.
PubMedID- 24790989 Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.
PubMedID- 25732129 Methods: forty systemic lupus erythematosus women with cardiovascular disease (systemic lupus erythematosus cases), 40 systemic lupus erythematosus women without cardiovascular disease, and 40 healthy controls were enrolled in this study.
PubMedID- 26354963 Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.
PubMedID- 20191526 Objective: to investigate the association between physical activity, functional activity of high-density lipoprotein (hdl), and subclinical cardiovascular disease in patients with systemic lupus erythematosus (sle).
PubMedID- 24470118 25-hydroxyvitamin d and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort.
PubMedID- 22210142 Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies.
PubMedID- 22126778 Objective: to investigate the prevalence of cardiovascular diseases (cvd) in patients with systemic lupus erythematosus (sle) and estimate the associated risk factors for cvd.
PubMedID- 24787906 Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.
PubMedID- PMC3467499 Our study investigates whether serum α-clfa may be a biomarker for subclinical cardiovascular disease (cvd) in patients with systemic lupus erythematosus (sle).
PubMedID- 21360503 Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation.
PubMedID- 24658835 Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.
PubMedID- 23942785 Increased serum levels of s100a8/a9 and s100a12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.

Page: 1